Abstract
A 7-year-old boy visited our hospital for a detailed examination of proteinuria identified in a school urinary test. He had short stature, misaligned teeth, and mild intellectual disability. A urinary examination identified mild proteinuria and extremely high levels of beta-2 microglobulin. On blood examination, his protein, albumin, and creatinine levels were found to be normal; however, his lactate dehydrogenase and creatinine phosphokinase levels were slightly elevated. Upon histological examination, no abnormalities in glomeruli or tubules were found. Considering these results, we diagnosed our patient with Dent disease type 2 (DD2). Although the whole exome sequencing revealed large deletion of OCRL, which was seen only in Lowe syndrome and not in DD2 previously, our final diagnosis for the patient is DD2. A phenotypic continuum exists between Dent disease and Lowe syndrome, and several factors modify the phenotypes caused by defects in OCRL. Although patients have thus far been diagnosed with DD2 or Lowe syndrome on the basis of their symptoms, accumulation and analysis of cases with OCRL defects may hereafter enable more accurate diagnoses.
Similar content being viewed by others
References
Gianesello L, Prete DD, Anglani F, et al. Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon. Hum Genet. 2021;140:401–21.
Bökenkamp A, Böckenhauer D, Cheong HI, et al. Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr. 2009;155(1):94–9.
Utsch B, Bökenkamp A, Benz MR, et al. Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis. 2006;48(6):942.e1-14.
Bökenkamp A, Ludwig M. The oculocerebrorenal syndrome of Lowe: an update. Pediatr Nephrol. 2016;31:2201–12.
Suarez-Artiles L, Perdomo-Ramirez A, Ramos-Trujillo E, et al. Splicing analysis of exonic OCRL mutations causing Lowe syndrome or Dent-2 disease. Genes. 2018. https://doi.org/10.3390/genes9010015.
Addis M, Meloni C, Tosetto E, et al. An atypical Dent’s disease phenotype caused by co-inheritance of mutations at CLCN5 and OCRL genes. Eur L Hum Genet. 2013;21:687–90.
McCrea H, Paradise S, Tomasini L, et al. All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding. Biochem Biophys Res Commun. 2008;369(2):493–9.
Hichri H, Rendu J, Monnier N, et al. From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat. 2011;32(4):379–88.
Montjean R, Aoidi R, Desbois P, et al. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells. Hum Mol Genet. 2015;24(4):994–1006.
Shrimpton AE, Hoopes RR, Knohl SJ, et al. OCRL1 mutations in Dent 2 patients suggest a mechanism for phenotypic variability. Nephron Physiol. 2009;112:27–36.
Recker F, Reutter H, Ludwig M. Lowe syndrome/Dent-2 disease: a comprehensive review of known and novel aspects. J Pediatr Genet. 2013;2:53–68.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Ethics approval
This article does not contain any studies with human participants performed by any of the authors.
Informed consent
Written informed consent was obtained from the patient and his guardian for the publication of this case report and any accompanying images.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Motoyoshi, Y., Yabuuchi, T., Miura, K. et al. A case of Dent disease type 2 with large deletion of OCRL diagnosed after close examination of a school urinary test. CEN Case Rep 11, 366–370 (2022). https://doi.org/10.1007/s13730-022-00685-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-022-00685-3